Public recall detail

Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic

medium
Recall Safety notice
Quick summary

Quick summary: Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Issue

Sotrovimab was authorized for use in relation to the COVID-19 pandemic, in accordance with the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. To provide earlier access to the product in the context of the global pandemic, GlaxoSmithKline will distribute sotrovimab with European French and English labelling in Canada.

Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...